111 (YI) Other financing activities (2020 - 2021)
111 (YI) reported Other financing activities of -$99.9 million for Q4 2021, up 38.75% on a YoY basis from -$72.0 million in Q4 2020, and down 191.87% sequentially from $108.7 million in Q3 2021.
111 (YI) Other financing activities (2020 - 2021) Analysis & Trends
111 (YI) has 2 years of Other financing activities data on file, last reported at -$99.9 million in Q4 2021.
- For the quarter ending Q4 2021, Other financing activities rose 38.75% year-over-year to -$99.9 million; the trailing twelve-month figure through Dec 2021 stood at $6.6 million (changed N/A YoY), and the FY2025 full-year result was $7.6 million, up 4450.6% from the prior year.
- Other financing activities eased to -$99.9 million in Q4 2021, from $108.7 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $160.8 million in Q3 2020 to a low of -$163.0 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -99.86 Mn |
| Dec 31, 2021 | -99.86 Mn |
| Sep 30, 2021 | 108.69 Mn |
| Sep 30, 2021 | 108.69 Mn |
| Dec 31, 2020 | -163.03 Mn |
| Dec 31, 2020 | -163.03 Mn |
| Sep 30, 2020 | 160.80 Mn |
| Sep 30, 2020 | 160.80 Mn |